“…Alteration of ER protein folding capacity may cause an increased proportion of unfolded and misfolded proteins in ER lumen which triggers loss of ER homeostasis and proteostasis and generates a detrimental cellular environment [ 6 , 7 , 8 ]. Several molecular and biophysical mechanisms are triggered to reverse and restore ER homeostasis such as (1) ER-associated degradation (ERAD), which triggers the misfolded protein degradation from ER lumen; (2) Unfolded protein response (UPR) involving the restoration of ER proteostasis by activation of three transduction signalling –IRE1, ATF6 and PERK branch-; and (3) Reticulophagy, the process of ER remodelling by autophagy of membranes and associated proteins (see reviews [ 9 , 10 , 11 , 12 , 13 , 14 ]). Pathophysiological factors occurring in cardiovascular diseases (CVDs) such as metabolic derangement, hypoxia, hypertrophy or inflammation require an increased protein expression, thus enhancing the disruption of the cellular proteostasis [ 15 , 16 , 17 , 18 , 19 , 20 , 21 ].…”